Development and Validation of a Nomogram for Patients with Nonmetastatic BCLC Stage C Hepatocellular Carcinoma after Stereotactic Body Radiotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Development and Validation of a Nomogram for Patients with Nonmetastatic BCLC Stage C Hepatocellular Carcinoma after Stereotactic Body Radiotherapy ; volume:9 ; number:3 ; year:2020 ; pages:326-337
Liver cancer ; 9, Heft 3 (2020), 326-337
- Creator
-
Huang, Wen-Yen
Tsai, Chiao-Ling
Que, Jenny Y.
Lo, Cheng-Hsiang
Lin, Yu-Ju
Dai, Yang-Hong
Yang, Jen-Fu
Shen, Po-Chien
Lee, Mei-Hsuan
Cheng, Jason Chia-Hsien
- DOI
-
10.1159/000505693
- URN
-
urn:nbn:de:101:1-2020081300100957118686
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Huang, Wen-Yen
- Tsai, Chiao-Ling
- Que, Jenny Y.
- Lo, Cheng-Hsiang
- Lin, Yu-Ju
- Dai, Yang-Hong
- Yang, Jen-Fu
- Shen, Po-Chien
- Lee, Mei-Hsuan
- Cheng, Jason Chia-Hsien
Other Objects (12)
Efficacy of stereotactic body radiotherapy in patients with hepatocellular carcinoma not suitable for transarterial chemoembolization (HERACLES: HEpatocellular Carcinoma Stereotactic RAdiotherapy CLinical Efficacy Study)
Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma
Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study
Predictive factors for survival following stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumour thrombosis and construction of a nomogram
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease
Managing hepatocellular carcinoma across the stages: efficacy and outcomes of stereotactic body radiotherapy
Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis
Health economic evaluation of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma: a systematic review
Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma
Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma
Combining stereotactic body radiotherapy with camrelizumab for unresectable hepatocellular carcinoma: a single-arm trial
Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter arterial chemoembolization in hepatocellular carcinoma
Efficacy of stereotactic body radiotherapy in patients with hepatocellular carcinoma not suitable for transarterial chemoembolization (HERACLES: HEpatocellular Carcinoma Stereotactic RAdiotherapy CLinical Efficacy Study)
Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma
Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study
Predictive factors for survival following stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumour thrombosis and construction of a nomogram
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease
Managing hepatocellular carcinoma across the stages: efficacy and outcomes of stereotactic body radiotherapy
Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis
Health economic evaluation of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma: a systematic review
Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma
Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma
Combining stereotactic body radiotherapy with camrelizumab for unresectable hepatocellular carcinoma: a single-arm trial
Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter arterial chemoembolization in hepatocellular carcinoma
Efficacy of stereotactic body radiotherapy in patients with hepatocellular carcinoma not suitable for transarterial chemoembolization (HERACLES: HEpatocellular Carcinoma Stereotactic RAdiotherapy CLinical Efficacy Study)
Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma
Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study
Predictive factors for survival following stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumour thrombosis and construction of a nomogram
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease
Managing hepatocellular carcinoma across the stages: efficacy and outcomes of stereotactic body radiotherapy
Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis
Health economic evaluation of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma: a systematic review
Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma
Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma
Combining stereotactic body radiotherapy with camrelizumab for unresectable hepatocellular carcinoma: a single-arm trial